Mastek Ltd. Share Price

Overview

Mastek Ltd. share price is currently ₹1,530.06, down by - ₹18.39 (1.19%) from its previous closing price of ₹1,548.45. The share price has declined -14.08% over the past month and declined -29.38% over the past year. The stock's 52-week low and high are ₹1,316.17 and ₹2,351.85, respectively. Mastek Ltd. has a market capitalisation of ₹ 4,820.00 Cr. The share price was last updated on 01 Oct 2026, 03:58 PM IST.

Mastek Ltd.
Mastek Ltd.
MASTEK
 ₹0.00
- ₹18.39
1.19%
IT
 ₹0.00(%)1D

Updated: 01 Oct 2026, 03:58:28 pm IST

Market Data

Open Price

 ₹1,537.53

Prev. Close

 ₹1,548.45
 ₹1,510.12

Day Low

 ₹1,561.68

Day High

 ₹1,316.17

52 Week Low

 ₹2,351.85

52 Week High

ITIT - Software
CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

11.35

Sector PE

19.63

PB Ratio

1.59

Sector PB

4.43

EPS

134.83

Dividend Yield

1.79

Today's Volume

144.889 K

5 Day Avg. Volume

112.011 K

PEG Ratio

1.56

Market Cap.

₹ 4,820.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 320% at ₹16/Share
31-Aug-202631-Aug-2026
DividendsInterim Dividend of 160% at ₹8/Share
30-Jan-202630-Jan-2026
DividendsFinal Dividend of 320% at ₹16/Share
12-Sep-202512-Sep-2025
DividendsInterim Dividend of 140% at ₹7/Share
24-Jan-202524-Jan-2025

Mutual Fund Ownership

Mutual Fund Holder
Jul 26
Shares held
Aug 26
Shares held
HDFC Small Cap Fund - Regular Plan - Growth15.80 Lac
15.80 Lac
no change
Bandhan Small Cap Fund - Regular Plan - Growth9.75 Lac
11.13 Lac
(14.11%)
ICICI Prudential Technology Fund - Growth10.07 Lac
10.07 Lac
no change
Tata Digital India Fund - Regular Plan - Growth5.81 Lac
5.81 Lac
no change
Bandhan Large & Mid Cap Fund - Regular Plan - Growth3.19 Lac
3.19 Lac
no change

About Mastek Ltd. 👋

Mastek Limited provides enterprise digital and cloud transformation solutions. Its segments include the United Kingdom, North America, and AMEA. The portfolio of the Company's offering includes business and technology services comprising application development, application maintenance, business intelligence and data warehousing, testing and assurance and legacy modernization. Its services include digital and application engineering, Oracle cloud and enterprise apps, digital experience & engineering, cloud implementations, data, automation and artificial intelligence (AI). Its GenAI-enabled portfolio, iConniX, offers over 120 AI assets, four AI platforms, and solution blueprints tailored to meet industry-specific business use cases. It caters to various industries, including the public sector and government; healthcare and life sciences; retail and consumer; manufacturing and technology; financial services, and construction and engineering.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
saurabh mittal

saurabh mittal

15 Sep • 6:56 AM · SEBI-Registered Analyst

Mastek Ltd ₹16 final dividend approval at the 44th AGM

MASTEK
At the 44th AGM held on September 7, 2026 (via video conferencing), shareholders adopted the audited FY26 financials and approved a final dividend of ₹16 per equity share (320% on ₹5 face value), taking the total FY26 dividend to ₹24 per share including the earlier ₹8 interim dividend. The meeting also reappointed Umang Nahata as a director liable to retire by rotation. Separately, Marilyn Jones ceased to be an Independent Director on September 4, 2026 upon completion of her tenure. After a 7.22% weekly decline in the first week of September, the stock recovered about 1% to ₹1,626.30 by September 11, with a market capitalisation near ₹5,040 crore and a dividend yield around 1.4%. the cessation of independent director Marilyn Jones, and a modest share‑price rebound after a volatile week.

See More
Rahul Porwal

Rahul Porwal

28 Aug • 10:33 PM · SEBI-Registered Analyst

Mastek shares surged nearly 20% today, hitting ₹1,935 on BSE

MASTEK
Mastek shares surged nearly 20% today, hitting ₹1,935 on BSE, after announcing Q2 FY26 results with profits of ₹97.45 crore and revenue of ₹940.37 crore. Brokerages see it as a potential turnaround story, driven by AI-led deals and strong order visibility. 📊 Mastek Q2 FY26 Results Revenue: ₹940.37 crore (up 2.81% QoQ, 8.41% YoY) Operating Profit: ₹127.64 crore (7.35% QoQ decline) Net Profit (PAT): ₹97.45 crore (down 24.25% YoY) Operating Margin: 13.57% EPS: ₹31.24 (down 16.6% YoY) 📈 Stock Market Performance BSE Price: ₹1,908.60 (+18.36%) NSE Price: ₹1,901.40 (+17.98%) Day’s High: ₹1,935 52-Week Range: ₹1,334 – ₹2,625 Trading Volume: 5.45 million shares on NSE Mastek was the top gainer in BSE’s ‘A’ group, rising over 13% by midday and later touching 20% gains.

See More
Adarsh Nimborkar (SEBI IA)

Adarsh Nimborkar (SEBI IA)

28 Aug • 11:28 AM · SEBI-Registered Analyst

Mastek Ltd – Company Fundalamental Analysis

MASTEK
Mastek Ltd is a global digital engineering and cloud transformation company serving government, healthcare, retail, manufacturing and financial-services clients, with a particularly strong presence in the UK and North America. Its capabilities span cloud modernization, Oracle, Salesforce, data, automation and increasingly artificial intelligence. The company's “Lead with AI” strategy is gaining traction, with around 45% of new order bookings in Q1 FY27 coming from AI-related deals. Financially, Mastek continues to show healthy growth and a strong balance sheet. Q1 FY27 revenue reached approximately ₹985 crore, up 5% sequentially, while net profit was around ₹106 crore. The 12-month order backlog increased 25% year-on-year in rupee terms to ₹2,935 crore, providing good revenue visibility. EBITDA margin, however, declined sequentially to 15.4%, partly because of delayed collections in the Middle East. The company had ₹945 crore of cash and investments at the end of June 2026, while debt-to-equity is only around 0.15. Looking ahead, Mastek's biggest opportunity is converting its growing AI capabilities and order backlog into sustained double-digit growth. Strong demand from UK healthcare and public-sector clients, increasing AI-led engagements and expansion in North America provide multiple growth drivers. However, investors should monitor margin sustainability, Middle East geopolitical exposure, client concentration and the company's ability to maintain order-book growth as the current valuation already reflects some recovery expectations. Overall, Mastek combines improving growth, a strong balance sheet, healthy cash generation and a relatively reasonable valuation. The key investment trigger is whether AI-led demand can accelerate revenue growth while keeping margins near or above 15%. If that happens, the current valuation could offer meaningful upside; if growth remains only mid-single digit, the re-rating potential would be much more limited.

See More
Dhwani Patel

Dhwani Patel

23 Aug • 10:13 PM · SEBI-Registered Analyst

Mastek Emerges as a Strong AI-Led IT Play

MASTEK
is positioning itself as a focused AI-led digital transformation player within the mid-cap IT space, with its Lead with AI strategy increasingly translating into actual order wins. Q1 FY27 revenue rose 5% QoQ to ₹985.3 crore, while the 12-month order backlog increased 25% YoY to ₹2,935 crore, providing improving revenue visibility. More importantly, the company secured 40+ AI-led deals during the quarter, with roughly 45% of new order bookings coming from AI deals. Its Data, Automation and AI business has also expanded meaningfully, while strong exposure to healthcare, government, financial services and enterprise transformation gives Mastek several structural growth opportunities. Cash and investments stood at about ₹945 crore, strengthening the balance sheet. The key risk remains that overall revenue growth is still moderate and EBITDA margin slipped to 15.4% in Q1, while the Middle East business remains affected by geopolitical uncertainty. Nevertheless, accelerating AI adoption, rising order visibility and improving productivity make Mastek an interesting AI-focused IT play. Technically, Mastek appears to be attempting a meaningful recovery after a prolonged corrective phase from the ₹3,000–₹3,400 region. The chart shows the stock finding repeated support around ₹1,450–₹1,500, forming a broad base from which the latest recovery has emerged. Price has now moved back above ₹1,700, indicating improving demand and a potential change in the intermediate trend.

See More
Saurabh Tyagi--Clovek,Advisory

Saurabh Tyagi--Clovek,Advisory

26 Jul • 9:12 PM · SEBI-Registered Analyst

MASTEK
Consolidated Financial Highlights:

MASTEK
Consolidated Financial Highlights: Total Income: Reported at Rs 99,728 lakh in Q1FY27. This reflects a QoQ growth of 3.68% compared to Rs 96,187 lakh in Q4FY26, and a YoY increase of 7.78% compared to Rs 92,526 lakh in Q1FY26. Total Income for FY26 stood at Rs 3,76,916 lakh. Revenue from Operations: Stood at Rs 98,525 lakh in Q1FY27, marking a QoQ increase of 5.04% (from Rs 93,800 lakh in Q4FY26) and a YoY growth of 7.71% (from Rs 91,470 lakh in Q1FY26). For FY26, it was Rs 3,69,875 lakh. Profit Before Tax (PBT): Recorded at Rs 13,846 lakh in Q1FY27, indicating a QoQ increase of 10.56% (from Rs 12,523 lakh in Q4FY26) and a YoY growth of 14.71% (from Rs 12,070 lakh in Q1FY26). FY26 PBT was Rs 52,122 lakh. Net Profit for the Period (PAT): Reached Rs 10,588 lakh in Q1FY27, showing a marginal QoQ decline of 0.25% (vs Rs 10,615 lakh in Q4FY26) but a YoY increase of 15.02% (vs Rs 9,205 lakh in Q1FY26). FY26 PAT was Rs 40,400 lakh. Earnings Per Share (EPS): Basic EPS was Rs 34.16 in Q1FY27, down 0.26% QoQ (from Rs 34.25 in Q4FY26) but up 14.82% YoY (from Rs 29.75 in Q1FY26). EPS for FY26 was Rs 130.45.

See More
Chahat Aggrawal

Chahat Aggrawal

21 Jul • 9:06 PM · SEBI-Registered Analyst

Mastek Reports 15% Growth in Q1FY27 Net Profit

💻

MASTEK
reported a 15% year-on-year increase in consolidated net profit to ₹1,058 crore for Q1FY27. Revenue rose 7.7% to ₹9,852 crore, supported by strong performance in the company's UK & Europe business.

See More

Frequently Asked Questions

What is the share price of Mastek Ltd.?

What is the market cap of Mastek Ltd.?

Should I buy Mastek Ltd. stock now?

What is the 52 week high and low of Mastek Ltd.?

Is the Mastek Ltd. stock good to buy?

Is Mastek Ltd. a good buy for the long term?

Is Mastek Ltd. overvalued or undervalued?

What is the PE and PB ratio of Mastek Ltd.?

Start Now